Form D · Other Health Care
2020, Inc.
Boston, MA · CIK 0001608616
Offering snapshot reported Jun 29, 2018 · SEC filing
- Reported sold
- $4.08M Offering amount: $7.83M
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 14, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 29, 2018 | Initial | $4,083,267 | No comparison | 28 | SEC filing |
| Sep 1, 2016 | Amendment | $6,699,965 | $3,200,000vs Jun 1, 2015 | 59 | SEC filing |
| Jun 1, 2015 | Initial | $3,499,965 | No comparison | 43 | SEC filing |
| May 20, 2014 | Initial | $1,215,000 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-315843
Amount sold shown in item 13 and number of investors shown in item 14 includes $3,963,482 from 9 non-US investors. $1,828,269 is from the conversion of notes and unpaid accrued interest.
Source: Form D, filed Jun 29, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Howard Bornstein | Director, Executive |
| John M. Connolly | Director |
| Ro Ann Costin | Director |
| Jason Dinges | Director |
| Dylan M. Hardy | Director |
| Stephanie O'brien | Director |
| Mark Weikel | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
222 Berkeley St., 12th Floor
Boston, MA, 02116
Boston, MA, 02116